TrialHypertension research : official journal of the Japanese Society of Hypertension2019

Long-term phase 3 study of esaxerenone as mono or combination therapy with other antihypertensive drugs in patients with essential hypertension.

Hiromi Rakugi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.